Literature DB >> 3973009

Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.

E S Krul, M J Tikkanen, T G Cole, J M Davie, G Schonfeld.   

Abstract

Apoproteins B and E both interact with cellular low density lipoprotein (LDL) apolipoprotein B and E (apo B,E)-receptors, and very low density lipoproteins (VLDL) contain both apo B and apo E. Our aim was to study the relative importance of apo B and apo E in the binding of VLDL subfractions to cells. Two monoclonal anti-LDL-apo B antibodies (464B1B3 and 464B1B6, 2a and 2b, respectively) and two anti-apo E antibodies (1506 A1.4 and 1907 F6.4) were used to inhibit lipoprotein-cell interactions. In confirmation of previous findings, the binding and degradation of 125I-LDL by human fibroblasts were inhibited approximately 90% by antibodies 2a or 2b or the antigen-binding fragments of 2a, whereas the cellular processing of 125I-VLDL3 (Sf20-60), 125I-VLDL2 (Sf60-120), and 125I-VLDL1 (Sf greater than 120) were inhibited by only approximately 50%, approximately 25%, and less than 10%, respectively. The VLDL1-3 and LDL-dependent intracellular esterification of cholesterol with [3H]oleate were inhibited to a similar extent. Other monoclonal anti-human apo B antibodies inhibited lipoprotein-cell interactions much less effectively and nonimmune IgG isolated from mouse serum did not inhibit at all. 20-fold excesses of LDL produced about the same patterns of inhibition of degradation of 125I-VLDL1-3 and LDL by cells as did antibodies 2a and 2b, whereas homologous unlabeled VLDL1-3 in like amounts inhibited the matched 125I-VLDL subfraction more effectively. Two anti-apo E monoclonal antibodies and a polyclonal anti-apo E antibody inhibited cell-mediated degradation of and lipoprotein-dependent cholesterol esterification by VLDL1 but not VLDL3 or LDL. The results suggest that receptor recognition sites on apo E in preference to sites on apo B mediate the cellular binding of hypertriglyceridemic VLDL1. However, the proportion of particles bound via apo B seems to increase as VLDL decreases in size toward LDL, and virtually all of LDL binding is mediated by apo B.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3973009      PMCID: PMC423494          DOI: 10.1172/JCI111708

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

2.  Characterization of the apolipoprotein B polypeptide of human plasma low density lipoprotein in detergent and denaturation solutions.

Authors:  J C Steele; J A Reynolds
Journal:  J Biol Chem       Date:  1979-03-10       Impact factor: 5.157

3.  Changes in apolipoproteins and properties of rabbit very low density lipoproteins on induction of cholesteremia.

Authors:  V G Shore; B Shore; R G Hart
Journal:  Biochemistry       Date:  1974-04-09       Impact factor: 3.162

4.  Antigenic mapping of human low density lipoprotein with monoclonal antibodies.

Authors:  N J Tikkanen; R Dargar; B Pfleger; B Gonen; J M Davie; G Schonfeld
Journal:  J Lipid Res       Date:  1982-09       Impact factor: 5.922

Review 5.  Lipoprotein receptors and cholesterol homeostasis.

Authors:  R W Mahley; T L Innerarity
Journal:  Biochim Biophys Acta       Date:  1983-05-24

6.  Abnormal suppression of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by hypertriglyceridemic very low density lipoprotein subclasses.

Authors:  S H Gianturco; C J Packard; J Shepherd; L C Smith; A L Catapano; H D Sybers; A M Gotto
Journal:  Lipids       Date:  1980-06       Impact factor: 1.880

7.  One-step purification of mouse monoclonal antibodies from ascitic fluid by DEAE Affi-Gel blue chromatography.

Authors:  C Bruck; D Portetelle; C Glineur; A Bollen
Journal:  J Immunol Methods       Date:  1982-09-30       Impact factor: 2.303

8.  The effect of human C apolipoproteins on the in vitro hepatic metabolism of triglyceride emulsions in the rat.

Authors:  S H Quarfordt; G Michalopoulos; B Schirmer
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

9.  Expression of apolipoprotein B epitopes in very low density lipoprotein subfractions. Studies with monoclonal antibodies.

Authors:  M J Tikkanen; T G Cole; K S Hahm; E S Krul; G Schonfeld
Journal:  Arteriosclerosis       Date:  1984 Mar-Apr

10.  Heterogeneity of lipoprotein particles in hepatic Golgi fractions.

Authors:  K E Howell; G E Palade
Journal:  J Cell Biol       Date:  1982-03       Impact factor: 10.539

View more
  17 in total

1.  Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.

Authors:  M M Véniant; V Pierotti; D Newland; C M Cham; D A Sanan; R L Walzem; S G Young
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

2.  Lipoprotein binding to cultured human hepatoma cells.

Authors:  F Krempler; G M Kostner; W Friedl; B Paulweber; H Bauer; F Sandhofer
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

3.  Phospholipids as modulators of hepatic recognition of chylomicron remnants. Observations with emulsified lipoprotein lipids.

Authors:  J Borensztajn; T J Kotlar
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

4.  Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women.

Authors:  E A Brinton; S Eisenberg; J L Breslow
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

5.  Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects.

Authors:  T Demant; D Bedford; C J Packard; J Shepherd
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

6.  Metabolism by human endothelial cells of very low density lipoprotein subfractions isolated from type 1 (insulin-dependent) diabetic patients.

Authors:  R L Klein; M F Lopes-Virella
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

7.  Distinct murine macrophage receptor pathway for human triglyceride-rich lipoproteins.

Authors:  S H Gianturco; A H Lin; S L Hwang; J Young; S A Brown; D P Via; W A Bradley
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

8.  Lipoprotein metabolism during acute inhibition of lipoprotein lipase in the cynomolgus monkey.

Authors:  I J Goldberg; N A Le; H N Ginsberg; R M Krauss; F T Lindgren
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

9.  Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor.

Authors:  W März; M W Baumstark; H Scharnagl; V Ruzicka; S Buxbaum; J Herwig; T Pohl; A Russ; L Schaaf; A Berg
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

10.  Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture.

Authors:  Kyung-Soo Chang; Jieyun Jiang; Zhaohui Cai; Guangxiang Luo
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.